Massachusetts Financial Services CO Amgen Inc Transaction History

Massachusetts Financial Services CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $821,175 - $939,760	-4,129 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $679,717 - $754,097	-2,910 Reduced 41.34%	4,129 $1.01 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $968,635 - $1.08 Million	4,128 Added 141.81%	7,039 $1.79 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $575,824 - $706,616	2,911 New	2,911 $687,000
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $9.13 Million - $10.9 Million	-52,461 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $4.79 Million - $5.61 Million	-28,727 Reduced 35.38%	52,461 $9.67 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $918,819 - $1.04 Million	-5,080 Reduced 5.89%	81,188 $15.4 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $476,328 - $556,027	-2,670 Reduced 3.0%	86,268 $16.8 Million
Q3 2018 Oct 25, 2018	SELL	$185.29 - $208.89 $10.3 Million - $11.6 Million	-55,525 Reduced 38.44%	88,938 $18.4 Million
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $5.86 Million - $6.58 Million	-35,301 Reduced 19.64%	144,463 $26.7 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $1.42 Million - $1.66 Million	-8,380 Reduced 4.45%	179,764 $30.6 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $2.25 Million - $2.52 Million	-13,337 Reduced 6.62%	188,144 $32.7 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $717,172 - $818,817	-4,287 Reduced 2.08%	201,481 $37.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	205,768	205,768 $35.4 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.